CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-14 | OYLER JOHN Chief Executive Officer | Sale | −1,790 | $211.63 | $379K | 1,800 |
| 2020-08-14 | OYLER JOHN Chief Executive Officer | Sale | −1,500 | $212.99 | $319K | 300 |
| 2020-08-14 | OYLER JOHN Chief Executive Officer | Sale | −300 | $214.06 | $64K | 0 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −681 | $211.01 | $144K | 13,762 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −1,731 | $211.93 | $367K | 12,031 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −800 | $213.56 | $171K | 11,231 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −3,743 | $214.44 | $803K | 7,488 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −5,585 | $215.30 | $1.2M | 1,903 |
| 2020-08-13 | OYLER JOHN Chief Executive Officer | Sale | −1,903 | $216.10 | $411K | 0 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −1,100 | $209.38 | $230K | 18,720 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −4,015 | $210.37 | $845K | 14,705 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −3,701 | $211.43 | $782K | 11,004 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −2,322 | $212.38 | $493K | 8,682 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −7,482 | $213.36 | $1.6M | 1,200 |
| 2020-08-12 | OYLER JOHN Chief Executive Officer | Sale | −1,200 | $214.00 | $257K | 0 |
| 2020-08-12 | Chen Timothy Yung-Cheng Director | Option exercise | +2,897 | $31.59 | $92K | 2,897 |
| 2020-08-12 | Chen Timothy Yung-Cheng Director | Sale | −2,897 | $212.00 | $614K | 0 |
| 2020-08-12 | Chen Timothy Yung-Cheng Director | Option exercise · Share Option (Right to Buy) | −37,661 | 266,926 | ||
| 2020-08-11 | Chen Timothy Yung-Cheng Director | Option exercise | +1,903 | $31.59 | $60K | 1,903 |
| 2020-08-11 | Chen Timothy Yung-Cheng Director | Sale | −1,000 | $212.41 | $212K | 903 |
Page 84 of 99 · 1,972 trades